14-3-3 zeta as novel molecular target for cancer therapy

Author： Matta Ajay   Siu KW Michael   Ralhan Ranju  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.5, 2012-05, pp. : 515-523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chromatin Organizer SATB1 As a Novel Molecular Target for Cancer Therapy

By  

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1603-1615

Bentham Science Publishers

Access to resources Recommend Favorite

TSC-22 (TGF-&bgr; Stimulated Clone-22): A Novel Molecular Target for Differentiation-Inducing Therapy in Salivary Gland Cancer

By  

Current Cancer Drug Targets, Vol. 4, Iss. 6, 2004-09 ,pp. : 521-529

Bentham Science Publishers

Access to resources Recommend Favorite

14-3-3ζ as a prognostic marker and therapeutic target for cancer

By Neal Christopher L   Yu Dihua  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1343-1354

Informa Healthcare

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphatase of regenerating liver: a novel target for cancer therapy

By Campbell Amanda M   Zhang Zhong-Yin  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 555-569

Informa Healthcare

Access to resources Recommend Favorite